QIAGEN - SAMPLE TO OUTCOME
LIVE

Serial Number

79264394

Owner

QIAGEN GMBH

Attorney

Keith A. Weltsch

Filing Date

May 9, 2019

Add to watchlist:

No watchlists yet
View on USPTO

QIAGEN - SAMPLE TO OUTCOME Trademark

Serial Number: 79264394 • Registration: 6104156

QIAGEN - SAMPLE TO OUTCOME is a trademark filed by QIAGEN GMBH on May 9, 2019. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

QIAGEN GMBH (212 trademarks)

HILDEN D-4010 , DE

Entity Type: 03

Trademark Details

Filing Date

May 9, 2019

Registration Date

July 21, 2020

Published for Opposition

May 5, 2020

Goods & Services

Downloadable and recorded computer software for data and document management, medical teaching; downloadable and recorded computer software and related downloadable databases for use in preparing and managing nucleic acid and protein assay analysis and for managing quality control, validation, interpretation, reporting, clinical decision support, data management, integration with medical records, physician portals, laboratory networking, professional healthcare and trial matching services all related to molecular and genomic analysis; downloadable and recorded computer software, namely, evidence-based decision support software used as an aid in the interpretation of variants observed in genomic sequencing data; downloadable and recorded computer software for evaluation of genomic variants in the context of software for searching and allocating published biomedical literature, professional association guidelines, publicly available databases and annotations, drug labels, and/or clinical-trials; downloadable and recorded computer software for preparing, interpretation and managing of bioinformatics analyses, optionally combined with data management, graphical viewing and output options; downloadable and recorded computer programs and software for biological data mining; downloadable and recorded computer programs and software for developing bioinformatics database for others; bio-chips for research or scientific purposes; DNA-chips; RNA-chips; next-generation sequencing (NGS) data processor; bioinformatics data processor; computer hardware and downloadable and recorded computer software for collecting, storing, analyzing, visualizing, and interpreting bioinformatics, genomics, and phenomics data sets; computer hardware and downloadable and recorded computer software for the monitoring of pathogens; downloadable computer databases for bioinformatics, genomics, phenomics, microbiome, metagenomics, organism-and -pathogen-specific genotype records, and organism and pathogen-specific phenotype information; downloadable and recorded computer software for use in the integration, analysis and visualization of biomedically relevant information allowing users to explore compound, target, assay, biological pathway and disease information; downloadable and recorded computer software and databases for the analysis of genomes, exomes, targeted amplicons, transcriptomes, and epigenetic NGS sequencing data; downloadable and recorded computer software, software development tools, and visualization software modules, for analysis, discovery, verification, and validation of disease biomarkers

Providing medical information and medical advice in the fields of retrieval, integration, correlation, analysis and interpretation of genomic data, sequencing data and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data and patient-specific data, molecular test results, clinical trial data; medical consulting services in the fields of health, medical care, biotechnology, bioinformatics, life sciences, pharmaceuticals and medicine; providing medical information in the fields of health, healthcare, life sciences, biotechnology, pharmaceuticals and pharmaceutical safety, bioinformatics, and genetic testing for medical purposes; medical consulting services with respect to the treatment and diagnosis of individuals; providing medical information on drug safety and drug compatibility in relation to therapy and the treatment of individuals; medical consulting services in the fields of diagnostics and patient treatment and treatment protocols; medical consulting services in the field of genomics and biological sequence processing and analysis for medical diagnosis and treatment purposes; providing medical information for the purposes of medical diagnosis and treatment in the field of molecular genetics; identification and testing of DNA samples for health care purposes; health care services, namely, medical genomics and data science consultancy to provide optimal health and disease prevention or treatment to patients; providing health information relating to genetics and diagnostics via the Internet; bioinformatics analysis for medical diagnostic and personalized treatment purposes; nucleic acid analysis and screening for medical diagnostic and treatment purposes

Medical diagnostic testing instruments for processing and analysis of genetic samples primarily for single-cell genomic, transcriptomic, or proteomic analysis; medical and diagnostic apparatus for testing DNA and RNA samples, using gene expression tests, gene expression profiling assays, genetic information and data, protein biomarkers, clinical data, and/or demographic information; testing apparatus for medical purposes for testing DNA and RNA samples sold as a unit with downloadable bioinformatics and machine learning algorithm software and medical data software to support treatment decisions; medical testing apparatus for testing DNA and RNA samples and quantifying biomarker levels and relative expression of host response genes; medical apparatus and instruments for detecting tumor cancer, heredity and genetic diseases; medical testing apparatus for samples of body fluids, tissue and organs; genome machine for medical purposes, namely, apparatus for DNA and RNA medical testing; diagnostic apparatus for the detection of cancer, genetic or heredity diseases

Providing temporary use of online non-downloadable software for use in collecting, organizing and managing data on bioinformatics, genomics, phenomics, microbiome, and metagenomics applications; hosting of computer databases featuring information relating to bioinformatics, genomics, phenomics, microbiome, metagenomics, organism- and pathogenspecific genotype records, and organism and pathogen-specific phenotype information; consulting relating to computer programming for acquiring, creating, sharing, managing, mining, analyzing, visualizing, interpreting and applying genomics and phenomics records; providing scientific analysis in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from patients; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's disease profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice; providing temporary use of on-line nondownloadable software and applications for genome analysis, developing personal treatment strategies for patients with diagnosed cancer and other diseases or disorders; conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; providing information about medical and scientific research in the field of bioinformatics to enable physicians and healthcare professionals to optimize treatment in clinical practice; computer programming services for medical reporting, namely, for creating, sharing, managing, mining, analyzing, visualizing, interpreting and applying genomics and phenomics records; scientific research services, namely, providing information relating to research in the field of specific molecular and genomic sciences for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from patients with cancer and other diseases and disorders

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 21, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 5, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 12, 2020 FICS
FINAL DISPOSITION PROCESSED
Nov 12, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 21, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 21, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 5, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 5, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 15, 2020 NONP
ASSIGNED TO LIE
Apr 2, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 25, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 25, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 25, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 25, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 25, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 5, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 4, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 4, 2020 TROA
REFUSAL PROCESSED BY IB
Sep 28, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 6, 2019 RFCS
REFUSAL PROCESSED BY MPU
Sep 6, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 14, 2019 RFCR
NON-FINAL ACTION WRITTEN
Aug 13, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Aug 13, 2019 MAFR
ASSIGNED TO EXAMINER
Aug 9, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 9, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 1, 2019 REPR